mortality/aging
• Background Sensitivity: survival to an average of 138 days, with most dying between 108-169 days of age; survival is slightly shorter than on a 129S1/Sv background
|
behavior/neurological
• slight, constant tremor develops at 7 weeks of age; increasing severity with age
|
• in a rotarod test, activity of mutants was normal until 14 weeks of age, then became severely reduced in ability compared to controls
• in a rocking rotating rod test, impaired performance was noted after 10 weeks of age
|
abnormal gait
(
J:94884
)
• observed with advanced age; hunched gait with outward pointing feet and splayed hind limbs and side to side shaking while walking
|
• decreased rearing activity
|
• apparent fatal startle seizures were observed that were induced by stimuli such as a loud noise
|
cellular
• accumulation of ceroid lipofuscin within the lysosomal compartment was observed from 48 days of age in neocortex samples; accumulation of additional material was seen with age; also observed in most other brain regions
• accumulation of curvilinear storage bodies was apparent in cortex at 35 days of age; was also observed in other tissues, but without overt cytopathology
|
nervous system
• apparent fatal startle seizures were observed that were induced by stimuli such as a loud noise
|
• neuronal degeneration of particular brain areas was observed; these areas include auditory pathways but not visual pathways
• mild atrophy of forebrain structures including the hippocampus and overlying neocortex; loss of neurons
|
• variable in extent and with age; most prominent in lobules III and IV of the cerebellum
|
demyelination
(
J:94884
)
• disorganized myelin sheaths with dilations suggesting degeneration
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
neuronal ceroid lipofuscinosis 2 | DOID:0110726 |
OMIM:204500 |
J:94884 |